bioRxivGeneticsPreprint
Gene expression profiling of The Cancer Genome Atlas supports an inverse association between body mass index (BMI) and major oesophageal tumour subtypes
Abstract
In the last decade the Cancer Genome Atlas (TCGA) program has revealed significant insights into molecular events of dozens of cancers. These data sets are continuously updated, providing an unprecedented resource to the research community. There is now an emerging link between obesity and the development and progression of cancer. In this study we wished to identify genes related to body mass index (BMI)-related in TCGA datasets. Supporting epidemiological data, our gene expression profiling analyses suggest that oesophageal adenocarcinoma (EAC) can be considered a true obesity-associated cancer subtype, presenting avenues for prevention and treatment.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Obesity promotes conserved inflammatory and metabolic transcriptional programs in mouse and human colon tumors
Elaine M. Glenny, Tengda Lin, … Stephen David Hursting·bioRxiv·Jun 19, 2025
- Hyperlipidemia drives tumor growth in a mouse model of obesity-accelerated breast cancer growth.
Renan Fudoli Lins Vieira, Sawyer R Sanchez, … Amandine Chaix·Cancer & MetabolismPeer-reviewed·Aug 28, 2025
- Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma
K. M. Chung, J. Singh, … M. D. Muzumdar·bioRxiv·Sep 26, 2019
- Obesity-driven changes in ECM composition promote local invasion and metastasis of breast tumors
A. Wishart, Y. Peng, … M. J. Oudin·bioRxiv·Jan 29, 2020
- Larger organ size caused by obesity is a mechanism for higher cancer risk.
H. Grant, Y. Zhang, … C. Tomasetti·bioRxiv·Jul 27, 2020
- Chronic obesity does not alter cancer incidence in Tp53R270H/+ mice
Ilaria Panzeri, Zachary Madaj, … John Andrew Pospisilik·Cancer Research CommunicationsPeer-reviewed·May 21, 2026